9-21227769-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021268.2(IFNA17):c.405G>A(p.Met135Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,614,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021268.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNA17 | NM_021268.2 | c.405G>A | p.Met135Ile | missense_variant | 1/1 | ENST00000413767.2 | NP_067091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNA17 | ENST00000413767.2 | c.405G>A | p.Met135Ile | missense_variant | 1/1 | 6 | NM_021268.2 | ENSP00000411940.2 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251394Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135890
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461822Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 727216
GnomAD4 genome AF: 0.000177 AC: 27AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.405G>A (p.M135I) alteration is located in exon 1 (coding exon 1) of the IFNA17 gene. This alteration results from a G to A substitution at nucleotide position 405, causing the methionine (M) at amino acid position 135 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at